Hypoxia-ischemia is accompanied by abundant corticosterone secretion that could exacerbate brain damage after the insult. The authors demonstrate that the steroid syn thesis inhibitor metyrapone (150 mg/kg subcutaneously) sup presses the hypoxia-ischemia-induced rise of plasma cortico sterone levels (17,3 ± 3,6 fLg/dL) when compared with corti costerone-treated animals (72,2 ± 4,8 fLg/dL) immediately after hypoxia-ischemia. In parallel, metyrapone reduced brain dam age (P < 0.05). Moreover, none of the metyrapone-treated ani mals displayed seizures, whereas seven of eight corticosterone-
Prolonged exposure to corticosterone causes hippo campal dendritic atrophy and may induce loss of hippo campal neurons (Sapolsky et aI., 1985; Woolley et aI., 1990) . A shorter period of exposure to high levels of corticosterone exacerbates loss of rat hippocampal neu rons in response to hypoxia-ischemia, neurotoxins, and seizures (e.g., Sapolsky and Pulsinelli, 1985) . Such in sults themselves are likely to be accompanied by el evated corticosterone levels that could worsen the out come of the insult. In accordance with this, we demon strated previously that reducing plasma corticosterone levels during hypoxia-ischemia by down-regulating the hypothalamo-pituitary-adrenal axis reduces neuronal damage after hypoxia-ischemia (Krugers et aI., 1995) . Moreover, we showed that this was accompanied with a reduction in seizures after hypoxia-ischemia.
Metyrapone inhibits the conversion of deoxycortico sterone in the rat adrenal cortex, thereby preventing the stress-induced elevation of plasma corticosterone levels treated animals had seizures after hypoxia-ischemia. Although corticosterone administration in metyrapone-treated animals el evated plasma corticosterone levels (39.0 ± 5.3 fLg/dL), this did not result in a subsequent increase in brain damage and seizures when compared with metyrapone-treated animals. The authors conclude that metyrapone reduces brain damage and the inci dence of seizures after hypoxia-ischemia but that this effect might partially be independent from its effect on modulating plasma corticosterone levels. Key Words: Brain damage
Corticosterone-E pilepsy-Hippocampus-I schemia. (Goodman Gilman et aI., 1985) . Hence, we hypothesize that metyrapone could reduce brain damage after hypox ia-ischemia by suppressing the insult-induced rise in corticosterone levels (Kemper et aI., 1994; Smith Swintoski et aI., 1996) . The present study was initiated to study whether metyrapone exerts a neuroprotective ac tion and alters the incidence of seizures after hypoxia ischemia. Also, in a preliminary study, we found that metyrapone caused anesthesia-like effects (Kemper et aI., 1994) . To establish this, we studied the effect of metyrapone on general activity of the animals.
MATERIALS AND METHODS

Animals and experimental treatments
All experiments were approved by the committee on animal bioethics of the University of Groningen. Male Wistar rats (250-300 g) were housed individually with a light-dark regi men (lights on from 8:00 AM-8:00 PM) and fed ad libitum.
Experiments were performed between 8:00 AM and I :00 PM, when basal plasma corticosterone levels are low. Of 27 rats, 7 received an injection with sesame oil (0.25 mL) 1 hour before hypoxia-ischemia (controls), and 8 animals received an injec tion with corticosterone (40 mg/kg subcutaneously) 1 hour be fore hypoxia-ischemia (CaRT) to produce elevated plasma corticosteroid levels (Sapolsky and Pulsinelli, 1985) . Six ani mals received an injection with metyrapone (150 mg/kg sub cutaneously) 4 hours before hypoxia-ischemia (MET) at a dos-age known to prevent the stress-induced rise in plasma corti costerone (Freo et aI., 1992) , and six other animals received an injection with both metyrapone (150 mg/kg subcutaneously) and corticosterone (40 mg/kg subcutaneously, MET + CORT).
Surgical procedures and hypoxia-ischemia
The animals were exposed to hypoxia-ischemia as described previously (Knollema et aI., 1995; Krugers et aI., 1995) .
Briefly, animals were anesthetized with halothane (0.9%).
Next, the left arteria femoralis was cannulated for continuous blood pressure monitoring during the normoxia and hypoxia! ischemia periods (Hewlett Packard Pressure Transducer, Boe blingen, Germany), and the right jugular vein was cannulated for determination of corticosterone and blood glucose levels.
Subsequently, the animals were intubated and ventilated (Infant Ventilator MK2, Loosco, Amsterdam, The Netherlands) for 10 minutes with 30% oxygen (02) and 70% nitric oxide (N20) (first normoxia period), for 20 minutes with 10% O2 and 90% N20 (hypoxia), and for 10 minutes with 30% O2 and 70% N20 (second normoxia period). During the hypoxia period, the left carotid artery was occluded (ischemia). The rectal temperature was maintained between 36.SOC and 37.5DC.
Histology
Twenty-four hours after hypoxia-ischemia, animals were anesthetized deeply with pentobarbital (50 mg/kg intraperito neally). Next, they were perfused transcardially with 0.9% sa line for 1 minute, followed by 4% paraformaldehyde in 0. 1 mollL phosphate-buffered saline (pH 7.4) for 10 minutes.
Brains were removed from the skull and postfixed in 4% para formaldehyde. Before cutting, the brains were cryoprotected by overnight storage in 30% sucrose in 0. 1 mollL phosphate buffer (pH 7.4), cut to 30-j..L m thick coronal sections at -15DC using a cryostat microtome, and collected in paraformaldehyde. The modified Gallyas silver impregnation procedure of Nadler and Evenson (1983) , which labels damaged cells and their pro cesses, was employed on free-floating sections, with all steps being identical and run simultaneously for all animals. For details of the procedure, see Ter .
Brain damage was determined in coronal sections of differ ent levels. Levels were 4.2, 5.7, 6.7, 7.7, and 9.2 mm from the interaural line (Paxinos and Watson, 1982) . The damage was determined using bright-and-dark field microscopy (Knollema et aI., 1995; Krugers et aI., 1995) . Camera lucida drawings of the silver staining in the ipsilateral side to the clamped artery were made on millimeter paper and used for damaged-area size calculations. Damage was expressed as the ratio between the area silver stained and the total area. The total damage per animal was calculated throughout the brain using the damage at the five levels and subsequently averaged per group. Data are expressed as mean ± SEM. Histology data, behavioral data, and plasma corticosterone levels were evaluated statistically, as de scribed previously (Knollema et aI., 1995; Krugers et aI., 1995) using the (two-tailed) Student's t test. Significance level was P < 0.05.
Quantification of plasma corticosterone levels
Blood samples were taken in the second normoxia period.
Subsequently, the samples were transferred to centrifuge tubes containing 10 j..L L heparin solution (500 units/mL) and centri fuged for 20 minutes at 3500 g. The supernatant was stored at -20DC for the corticosterone assay. Corticosterone was ex tracted from 75 j..L L of plasma using a liquid extraction method.
Plasma corticosterone levels were quantified with high pressure liquid chromatography in combination with ultraviolet detection (Shimizu et aI., 1983) . The absolute detection thresh old for corticosterone in plasma was 8 ng/mL.
Behavior
We measured the activity of the animals before hypoxia! ischemia to test whether the different treatments affected loco motor activity. We recorded the number of steps and rearings during a 3-minute period in the staircase test (Willig et aI., 199 1).
Seizures
To establish whether modulation of steroid levels during hypoxia-ischemia affected hypoxia-ischemia-induced sei zures, we recorded the number of animals per group that dis played visible seizures. Seizures were recorded from the period immediately after hypoxia-ischemia until perfusion 24 hours later.
RESULTS
Temperature, blood pressure, blood glucose, and plasma corticosterone levels Body temperature and blood glucose levels were not significantly different between the groups during the whole procedure (data not shown). During the normoxia periods, blood pressure was similar in all groups, whereas MET-treated animals had slightly elevated blood pressure during the hypoxia-ischemia period when compared with the other groups (Table 1) .
Control rats displayed very high plasma corticosterone levels shortly after 20 minutes of hypoxia-ischemia (59.9 ± 2.7 j,Lg/dL, Table 1 ). Pretreatment with cortico sterone significantly elevated the plasma steroid levels (72.7 ± 4.8 j,Lg/dL), whereas pretreatment with metyra- pone reduced plasma steroid levels (17.3 ± 3.6 IJ-g/dL). Corticosterone administration in these animals (MET + CORT) resulted in a marked and significant increase in the plasma steroid levels over metyrapone-treated ani mals (39.0 ± 5.3 IJ-g/dL).
Histology
Analysis of silver impregnation revealed striking ef fects of the treatments on brain damage, which appeared at least partially related to the plasma corticosteroid lev els. In control animals, the hippocampus, the dorsolateral parts of the striatum, the thalamic areas, and cortex were damaged (Fig. 1) . Total damage in control animals was 48.9 ± 9.1 %. Brain damage was evident particularly in the animals displaying extremely high corticosteroid lev els shortly after ischemia (CORT, total brain damage 65.8 ± 4.0%). Conversely, brain damage in animals pre treated with MET and MET + CORT (those with low plasma corticosteroid levels after hypoxia-ischemia) showed significantly less damage (P < 0.05) when com pared with CORT-treated animals (total brain damage 26.3 ± 12.8% and 25.7 ± l3.4%, respectively). Cortico- .� 00 20 sterone administration in MET animals did not influence brain damage when compared with MET animals.
Seizures
Three of seven animals in the control group displayed visible seizures during the 24-hour period after hypoxia ischemia (Table 1) . These seizures were characterized by spinning of the animal around its body-axis, jerking movements, and/or clonic contractions of the paws. The seizures were intermittent and lasted less than 30 sec onds. No between-group differences in the pattern of seizures was apparent. The number of animals displaying seizures showed a clear relationship with brain damage. In the CORT group, seven of eight animals displayed seizures whereas none of the metyrapone-treated animals displayed visible seizures. Corticosterone treatment of metyrapone-treated animals did not increase the number of visible seizures.
Behavior
Behavioral measurements before hypoxia-ischemia revealed that metyrapone affected activity of the animals. Metyrapone reduced both the number of steps and rear ings in the staircase test, indicating a reduced general locomotor activity (Willig et aI., 199 1; Table 1 ).
DISCUSSION
Considerable evidence indicates that elevated plasma corticosterone levels exacerbate neuronal damage in re sponse to excitotoxic events (Sapolsky and Pulsinelli, 1985; Stein and Sapolsky, 1988; Tombaugh and Sapol sky, 1992) . It has been hypothesized that corticosteroids endanger neurons by disrupting glucose uptake and as trocyte functioning, resulting in elevated glutamate lev els and an impaired capacity to maintain neuronal cal cium homeostasis during and after hypoxia-ischemia or seizures (Virgin et aI., 199 1; Tombaugh and Sapolsky, 1992; Stein-Behrens et aI., 1992; Elliot et aI., 1993; Stein-Behrens et aI., 1994) . Because cerebral ischemia and seizures can induce con siderable corticosterone secretion, corticosteroids could worsen the outcome of these insults. In the present study, we have shown that the steroid synthesis inhibitor me tyrapone reduces plasma corticosterone levels during and shortly after hypoxia-ischemia. As predicted, this is ac companied by increased cell survival and a reduced in cidence of seizures after hypoxia-ischemia when com pared with animals exhibiting very high plasma cortico sterone levels. These findings confirm our previous data (Kemper et aI., 1994) and the observations by Smith Swintosky et aI. (1996) that metyrapone reduces brain damage after middle cerebral artery occlusion and kainic acid-induced seizures. Essentially, this may indicate that the production of corticosteroids after injury contributes to the severity of hypoxia-ischemia-induced damage. Accordingly, we demonstrated that down-regulation of the hypothalamo-pituitary-adrenal axis prevents the re lease of glucocorticoids during hypoxia-ischemia and increased neuronal survival (Krugers et aI., 1995) . More over, our data show that metyrapone reduces the inci dence of seizures after hypoxia-ischemia. If-as our data at least partly demonstrate-corticosterone exacerbates brain damage after ischemia and seizures, this might have clinical implications. Accordingly, elevated urinary and plasma cortisol levels have proven to be predictive indicators of prognosis after stroke and status epilepticus (Olsson et aI., 1992; Gallagher et aI., 1984) .
The glucocorticoid receptor, rather than the mineralo corticoid receptor, appears to be involved in the cortico steroid endangerment of neurons (Packan and Sapolsky, 1990) . Our results in the present are in agreement with such a hypothesis because cells throughout the brain were protected by metyrapone, which coincides with the distribution of the glucocorticoid receptor (whereas the mineralocorticoid receptor is localized mainly in the hip pocampus, De Kloet, 199 1) .
We found that corticosterone treatment did increase plasma corticosterone levels over that of metyrapone treated animals, but this did not result in a subsequent increase in damage or seizures. Therefore, one might argue against a neuroprotective effect of metyrapone by suppressing the insult-induced rise in corticosterone. Me tyrapone reduces corticosteroid production by inhibition of the ll-l3-hydroxylation reaction, resulting in an in creased production of II-deoxycorticosterone (DOC, Goodman Gilman et aI., 1985) . Metabolites of DOC (such as 3a 21-dihydroxy-5a pregnan-20-one, 5a THDOC) are known for their anesthetic properties, pre sumably via gamma-amino butyric acidA -receptors (Lambert et aI., 1995) . Although we did not measure levels of these neuroactive steroids, we do have some indirect evidence for an anesthesia-like effect of metyra pone. Metyrapone-treated animals were tested for their locomotor activity in a staircase test: metyrapone re duced the activity of the rats in a staircase test. Because gamma-aminobutyric acid-ergic actions of neuroactive steroid actions may prevent excitotoxic brain damage, this could be an additional way to explain the neuropro tective effect of metyrapone (Lambert et aI., 1995) .
We conclude that the steroid synthesis inhibitor me tyrapone reduces neuronal damage and seizures after hy poxia-ischemia but that the nature of its neuroprotective action might be partially independent from suppressing the increase in plasma corticosteroid levels.
